Outcomes of adolescents and young adults with chronic-phase chronic myeloid leukaemia treated with tyrosine kinase inhibitors-Reference-Cited by-同舟云学术

Outcomes of adolescents and young adults with chronic-phase chronic myeloid leukaemia treated with tyrosine kinase inhibitors

Published:2022-04-29 Issue:1 Volume:54 Page:1244-1254
ISSN:0785-3890
Container-title:Annals of Medicine
language:en
Short-container-title:Annals of Medicine

Author:

Nishiyama-Fujita Yuriko¹^ORCID,Nakazato Tomonori¹^ORCID,Iriyama Noriyoshi²,Tokuhira Michihide³,Ishikawa Maho⁴,Sato Eriko⁵,Takaku Tomoiku⁶,Sugimoto Keiji⁷,Fujita Hiroyuki⁸,Fujioka Isao⁶,Tsuchiya Shun⁶,Kimura Yuta³,Iwanaga Eisaku⁹,Komatsu Norio⁶^ORCID,Asou Norio⁴,Kizaki Masahiro³,Hatta Yoshihiro²,Kawaguchi Tatsuya¹⁰

Affiliation:

1. Department of Hematology, Yokohama Municipal Citizen’s Hospital, Yokohama, Japan

2. Department of Medicine, Division of Hematology and Rheumatology, Nihon University School of Medicine, Tokyo, Japan

3. Department of Hematology, Saitama Medical Center, Saitama Medical University, Saitama, Japan

4. Department of Hemato-Oncology, International Medical Center, Saitama Medical University, Saitama, Japan

5. Department of Hematology, Juntendo University Nerima Hospital, Tokyo, Japan

6. Department of Hematology, Juntendo University School of Medicine, Tokyo, Japan

7. Department of Hematology, Juntendo University Urayasu Hospital, Urayasu, Japan

8. Department of Hematology, Saiseikai Yokohama Nanbu Hospital, Yokohama, Japan

9. Department of Hematology, Kumamoto University Hospital, Kumamoto, Japan

10. Medical Technology, Kumamoto Health Science University, Kumamoto, Japan

Funder

Bristol-Myers Squibb, Novartis Pharma K.K., Otsuka Pharmaceutical and Pfizer Inc

Publisher

Informa UK Limited

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/07853890.2022.2069280

Reference39 articles.

1. Risk and Cause of Death in Patients Diagnosed With Myeloproliferative Neoplasms in Sweden Between 1973 and 2005: A Population-Based Study

2. Quality Cancer Care for Adolescents and Young Adults: A Position Statement

3. The care of adolescents and young adults with cancer: results of the ESMO/SIOPE survey

4. Adolescent and Young Adult Oncology Progress Review Group. Closing the gap: research and care imperatives for adolescents and young adults with cancer. Report of the Adolescent and Young Adult Oncology Progress Review Group. U.S. Department of Health and Human Services, National Institute of Health, National Cancer Institute. 2006. NIH Publication No. 06–6067.

5. International evolution in AYA oncology: Current status and future expectations

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Characteristics and Outcomes of CML in Adolescents and Young Adults;Clinical Lymphoma Myeloma and Leukemia;2024-05

2. Clinical Characteristics and Outcomes of Cml in Adolescents and Young Adults;2024

3. Chronic Myeloid Leukemia in Adolescents and Young Adults: A SEER-Based Analysis of Characteristics and Survival Outcomes of 1565 Patients;Blood;2023-11-28

4. Asciminib in the Treatment of Philadelphia Chromosome-Positive Chronic Myeloid Leukemia: Focus on Patient Selection and Outcomes;Cancer Management and Research;2023-08

5. Current and emerging tyrosine kinase inhibitors for the treatment of chronic myeloid leukemia in young adults;Expert Opinion on Pharmacotherapy;2023-07-27